Skip to content

The effect of dignity therapy on quality of life, anxiety and depression in patients with chronic obstructive pulmonary disease

The effect of dignity therapy on quality of life, anxiety and depression in patients with chronic obstructive pulmonary disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211130053227N1
Enrollment
62
Registered
2022-05-24
Start date
2022-02-08
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease. Chronic lower respiratory diseases

Interventions

Intervention 1: Three 30–60 minute sessions will be considered for dignity therapy implementation. The interval between sessions will be scheduled at the patients’ convenience, usually within 1 to 3 d

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Sample tend to participate in the study age 18-70 years. Have a minimum reading and writing ability (in order to answer the questionnaire) grade 3 and 4 diseases based on GOLD scale Physical ability and no cognitive impairment (based on the mental status examination questionnaire to participate in sessions and answer the questionnaire) No major mental disorders (schizophrenia, paranoid disorders and major depression)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Before and one month after intervention. Method of measurement: Hospital Scale Depression and Anxiety.;Depression. Timepoint: Before and one month after intervention. Method of measurement: Hospital Scale Depression and Anxiety.;Quality of life. Timepoint: Before and one month after intervention. Method of measurement: St. George Respiratory Quality of Life Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Hojatollah Yousefi

Esfahan University of Medical Sciences

yousefi@nm.mui.ac.ir+98 31 3668 8138

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026